Clinical Vignettes, Part II: Eyes, Teeth, and Bone

Area of Science:

• Ophthalmology
• Hematology
• Orthopedics

Background:

• Sickle cell disease (SCD) leads to microvascular occlusions affecting various organs.
• Sickle cell retinopathy (SCR) is a common ocular complication, with proliferative SCR (PSR) causing vision loss.
• Osteonecrosis is a prevalent skeletal complication in SCD, impacting joint health and quality of life.

Purpose of the Study:

• To summarize the ophthalmic and skeletal complications of sickle cell disease.
• To highlight the importance of regular screening and timely interventions for SCD patients.

Main Methods:

• Review of common SCD-related ocular manifestations, focusing on retinopathy.
• Discussion of skeletal complications, particularly osteonecrosis.
• Emphasis on recommended management strategies for both conditions.

Main Results:

• Most individuals with SCR are asymptomatic, but PSR can lead to significant vision loss.
• Scatter laser photocoagulation is the standard treatment for vision-threatening PSR.
• Osteonecrosis causes progressive joint damage, pain, and reduced quality of life, with joint replacement considered.

Conclusions:

• Regular retinopathy screening and specialist follow-up are essential for preventing vision loss in SCD.
• Dental care is vital, requiring consultation with hematologists for surgical procedures.
• Management of osteonecrosis involves pain management, physical therapy, and potential joint arthroplasty.